Identificação de variantes de splicing sob influência da alta expressão do oncogene ERBB2 em câncer de mama

Abstract

Background. Alternative splicing (AS) is a central mechanism in the generation of genomic complexity and is a major contributor to transcriptome and proteome diversity. Alterations of the splicing process can lead to deregulation